Primary Medical Institutions Do Not Accept Bids For Imported Products

On May 27, 2022, the basic level medical institutions in Jiangsu Province, China, made public bidding. The bidding requirements clearly stipulated that the bid for imported products would not be accepted.

The total bidding amount is 100million yuan, equivalent to about 15million US dollars. The bidding products mainly include medical digital X-ray imaging system (flat DR), color Doppler ultrasound diagnostic instrument and portable color Doppler ultrasound diagnostic instrument.

 In the end, 257 sets of DR and other equipment were sold for 79.3418 million yuan.

It can be seen that the method of centralized procurement through packaging is much lower than that of hospital procurement alone, and this will eventually become the trend in the future.

In addition, some people must be puzzled that Philips and others won the bid as "domestic"! In fact, according to relevant policies, the category of "domestic" also includes products produced by foreign-funded enterprises in China.

More and more multinational machinery enterprises have begun to build factories in China. Philips, Ge, Medtronic, etc. have said that they will continue to promote "local manufacturing" and localize the entire industry chain.

Obviously, this is not a bad thing. The "localization" across the machinery enterprises will inject more strength and hope into the domestic medical equipment manufacturing industry, force the domestic medical equipment enterprises to develop innovatively, and further promote the rapid development of Chinese products to the international market.